Mitchell Bloom is Global Chair of Goodwin’s Life Sciences practice. Mitchell specializes in representing public and private life science companies, as well as venture capital firms and investment banks focused on the life sciences sector.
Mitchell's practice is focused on the representation of emerging and public life science companies, and he serves as principal outside or general counsel to leading life science companies. In addition to day-to-day corporate counseling and strategic advice to his clients, he regularly handles a variety of major business transactions, including public offerings, mergers and acquisitions, venture capital financings and strategic commercial transactions.
Mitchell is a member of the American, Massachusetts and Boston Bar Associations.
Prior to joining Goodwin, Mr. Bloom was a partner at Testa, Hurwitz & Thibeault in Boston, where he was a member of the Business Practice Group and co-chair of its Life Sciences Practice.
Boston College Law School
Recognition & Awards
Mitchell has been recognized by The Best Lawyers in America Best Lawyers for his work in Biotechnology and Life Sciences Practice, Corporate Law and Venture Capital Law 2022-2023.
Mitchell is recognized nationally for his leadership in the life sciences industry and has been included in numerous legal guides for his corporate finance and life sciences expertise, including Chambers USA: America’s Leading Lawyers for Business, Chambers Global, U.S. News-Best Lawyers and The Legal 500 United States. In addition, for the past two years he has been selected as a “Life Science Star” by LMG Life Sciences.
Mitchell is one of the leading life science capital markets lawyers in the U.S. and is the country’s most active attorney representing issuer-side life science IPOs since 2017.
Under his leadership, Goodwin’s Life Sciences practice has received numerous awards and honors, including U.S. News’ Biotechnology Law Firm of the Year numerous times and perennial nationwide recognition by Chambers USA, among other legal guides.